Ultragenyx Pharmaceutical Inc. Quarterly Operating Income (Loss) in USD from Q1 2013 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Ultragenyx Pharmaceutical Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2013 to Q3 2024.
  • Ultragenyx Pharmaceutical Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$132M, a 9.04% increase year-over-year.
  • Ultragenyx Pharmaceutical Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$536M, a 9.62% increase year-over-year.
  • Ultragenyx Pharmaceutical Inc. annual Operating Income (Loss) for 2023 was -$569M, a 12.3% increase from 2022.
  • Ultragenyx Pharmaceutical Inc. annual Operating Income (Loss) for 2022 was -$649M, a 70% decline from 2021.
  • Ultragenyx Pharmaceutical Inc. annual Operating Income (Loss) for 2021 was -$382M, a 15.6% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$536M -$132M +$13.1M +9.04% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-06
Q2 2024 -$549M -$116M +$31.6M +21.4% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-02
Q1 2024 -$580M -$165M -$11.2M -7.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-03
Q4 2023 -$569M -$122M +$23.6M +16.2% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-21
Q3 2023 -$593M -$145M +$80M +35.5% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-06
Q2 2023 -$673M -$148M -$6.36M -4.5% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-02
Q1 2023 -$666M -$154M -$17.5M -12.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-03
Q4 2022 -$649M -$146M -$43.1M -42% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-21
Q3 2022 -$606M -$225M -$135M -151% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-03
Q2 2022 -$471M -$142M -$58.8M -71.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-04
Q1 2022 -$412M -$137M -$30.1M -28.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-05
Q4 2021 -$382M -$103M -$6.48M -6.75% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-21
Q3 2021 -$375M -$89.8M -$39.5M -78.5% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 -$336M -$82.8M -$19.7M -31.3% Apr 1, 2021 Jun 30, 2021 10-Q 2022-07-29
Q1 2021 -$316M -$107M +$14.1M +11.7% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q4 2020 -$330M -$96.1M -$1.63M -1.73% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-17
Q3 2020 -$328M -$50.3M +$67.7M +57.4% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 -$396M -$63.1M +$49.4M +43.9% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-03
Q1 2020 -$446M -$121M -$21.5M -21.6% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 -$424M -$94.5M -$4.11M -4.55% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-15
Q3 2019 -$420M -$118M -$28.4M -31.7% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-27
Q2 2019 -$392M -$112M -$17.6M -18.5% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-31
Q1 2019 -$374M -$99.2M -$2.73M -2.83% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 -$371M -$90.3M +$6.49M +6.71% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-12
Q3 2018 -$378M -$89.6M -$5.93M -7.09% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-06
Q2 2018 -$372M -$94.9M -$16.5M -21% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-02
Q1 2018 -$355M -$96.5M -$26.5M -37.9% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
Q4 2017 -$329M -$96.8M -$26.3M -37.3% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-14
Q3 2017 -$303M -$83.7M -$17.9M -27.3% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-06
Q2 2017 -$285M -$78.4M -$20.4M -35.1% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-03
Q1 2017 -$264M -$70M -$16.3M -30.5% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q4 2016 -$248M -$70.5M -$14.4M -25.6% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-20
Q3 2016 -$234M -$65.8M -$25.8M -64.7% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-03
Q2 2016 -$208M -$58.1M -$27.9M -92.6% Apr 1, 2016 Jun 30, 2016 10-Q 2017-07-28
Q1 2016 -$180M -$53.6M -$32.1M -149% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-05
Q4 2015 -$148M -$56.2M -$39.2M -231% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-21
Q3 2015 -$109M -$39.9M -$24.1M -152% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-08
Q2 2015 -$84.4M -$30.1M -$16.5M -121% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 -$67.9M -$21.5M -$11.2M -108% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 -$56.8M -$16.9M -$7.42M -77.9% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-17
Q3 2014 -$49.4M -$15.8M -$8.07M -104% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-10
Q2 2014 -$41.3M -$13.7M -$5.41M -65.6% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-14
Q1 2014 -$35.9M -$10.3M -$3.59M -53.2% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-12
Q4 2013 -$32.3M -$9.53M Oct 1, 2013 Dec 31, 2013 10-K 2016-02-26
Q3 2013 -$7.76M Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-10
Q2 2013 -$8.25M Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-11
Q1 2013 -$6.75M Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.